Zimmer Biomet Holdings Net Change in Cash decreased by 122.8% to -$167.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 119.5%, from $859.10M to -$167.70M. Over 2 years (FY 2021 to FY 2023), Net Change in Cash shows an upward trend with a -64.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
A positive change indicates net cash generation, while a negative change indicates cash consumption for the period.
The total net increase or decrease in cash, cash equivalents, and restricted cash during the reporting period. It is the...
A fundamental liquidity metric used to compare cash management efficiency across all public companies.
net_change_in_cash| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $318.10M | -$122.80M | -$441.10M | -$42.70M | -$49.40M | $159.00M | -$169.70M | -$45.50M | -$10.40M | -$27.60M | $123.60M | -$22.70M | $27.10M | $148.90M | $859.10M | $735.80M | -$167.70M |
| QoQ Change | — | -138.6% | -259.2% | +90.3% | -15.7% | +421.9% | -206.7% | +73.2% | +77.1% | -165.4% | +547.8% | -118.4% | +219.4% | +449.4% | +477.0% | -14.4% | -122.8% |
| YoY Change | — | — | — | — | -115.5% | +229.5% | +61.5% | -6.6% | +78.9% | -117.4% | +172.8% | +50.1% | +360.6% | +639.5% | >999% | +394.2% | -119.5% |